Actuate Therapeutics ACTU
NASDAQ ACTU
$1.20 -0.03 (-2.44%)
As of: Aug 21, 2026 · 10:19 AM EDT

Actuate Therapeutics (ACTU) EPS (Basic) (2023 - 2025)

Actuate Therapeutics (ACTU) posted quarterly EPS (Basic) of -$0.22 for Q4 2025, up 71.29% year-over-year from -$0.13 in Q4 2024, and up 13.33% quarter-over-quarter from -$0.25 in Q3 2025.

Actuate Therapeutics (ACTU) EPS (Basic) (2023 - 2025) Analysis & Trends

Actuate Therapeutics (ACTU) has reported EPS (Basic) for 3 consecutive years, with -$0.22 the latest figure, recorded in Q4 2025.

  • In Q4 2025, EPS (Basic) rose 71.29% year-over-year to -$0.22; the TTM figure through Dec 2025 stood at -$1.06 (up 64.36% YoY), while the FY2025 annual figure was -$1.14, up 84.82% from the prior year.
  • EPS (Basic) rose to -$0.22 in Q4 2025 per ACTU's latest filing, from -$0.25 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.22 in Q4 2025 and bottomed at -$5.27 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$2.22 across 3 years, with a median of -$0.76 in 2024.
  • Annual changes were most pronounced in 2024 — EPS (Basic) advanced 11.73% — and 2025, when it surged 93.59%.
  • Actuate Therapeutics' EPS (Basic) stood at -$5.27 in 2023, then surged by 85.52% to -$0.76 in 2024, then surged by 71.29% to -$0.22 in 2025.
  • Business Quant data shows ACTU's EPS (Basic) at -$0.22 in Q4 2025, -$0.25 in Q3 2025, and -$0.3 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 140.52 Bn 132.67 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 86.54 Bn 78.55 Bn 3.93 Bn 12.62
3 Argenx Se 65.31 Bn 60.13 Bn 1.37 Bn 7.59
4 Moderna 61.77 Bn 56.64 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.26 Bn 37.16 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.19 Bn 27.88 Bn 992.69 Mn 1.23
7 BioNTech SE 28.71 Bn 10.31 Bn 668.28 Mn -0.72
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.35 Bn 26.52 Bn - 0.18
10 Actuate Therapeutics 28.65 Mn 28.65 Mn - -0.20

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.22
Sep 30, 2025 -0.25
Jun 30, 2025 -0.30
Mar 31, 2025 -0.32
Dec 31, 2024 -0.76
Sep 30, 2024 -0.49
Jun 30, 2024 -3.47
Mar 31, 2024 -5.06
Dec 31, 2023 -5.27
Sep 30, 2023 -4.32
Jun 30, 2023 -3.93